Kazuki Moro

621 total citations
27 papers, 483 citations indexed

About

Kazuki Moro is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Kazuki Moro has authored 27 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Surgery and 8 papers in Oncology. Recurrent topics in Kazuki Moro's work include Sphingolipid Metabolism and Signaling (8 papers), Lipid Membrane Structure and Behavior (6 papers) and Erythrocyte Function and Pathophysiology (3 papers). Kazuki Moro is often cited by papers focused on Sphingolipid Metabolism and Signaling (8 papers), Lipid Membrane Structure and Behavior (6 papers) and Erythrocyte Function and Pathophysiology (3 papers). Kazuki Moro collaborates with scholars based in Japan, United States and Australia. Kazuki Moro's co-authors include Toshifumi Wakai, Kazuaki Takabe, Junko Tsuchida, Masayuki Nagahashi, Masayuki Nagahashi, Emmanuel Gabriel, Rajesh Ramanathan, Miki Hasegawa, Tsutomu Kawaguchi and Qianya Qi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Kazuki Moro

24 papers receiving 468 citations

Peers

Kazuki Moro
Jessica K. Nelson Netherlands
Inês Cebola United Kingdom
John Stoops United States
Benjamin Y. Owusu United States
Jessica K. Nelson Netherlands
Kazuki Moro
Citations per year, relative to Kazuki Moro Kazuki Moro (= 1×) peers Jessica K. Nelson

Countries citing papers authored by Kazuki Moro

Since Specialization
Citations

This map shows the geographic impact of Kazuki Moro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuki Moro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuki Moro more than expected).

Fields of papers citing papers by Kazuki Moro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuki Moro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuki Moro. The network helps show where Kazuki Moro may publish in the future.

Co-authorship network of co-authors of Kazuki Moro

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuki Moro. A scholar is included among the top collaborators of Kazuki Moro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuki Moro. Kazuki Moro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ichikawa, Hiroshi, Masaki Aizawa, Yosuke Kano, et al.. (2024). Landscape of homologous recombination deficiency in gastric cancer and clinical implications for first-line chemotherapy. Gastric Cancer. 27(6). 1273–1286. 6 indexed citations
2.
Kano, Yosuke, Hiroshi Ichikawa, Yusuke Muneoka, et al.. (2024). [Thoracic Aortic Thrombosis during Preoperative 5-Fluorouracil plus Cisplatin Therapy for Esophageal Cancer].. PubMed. 51(13). 1428–1430.
3.
Ichikawa, Hiroshi, Masaki Aizawa, Yusuke Muneoka, et al.. (2024). Clinical application of targeted tumour sequencing tests for detecting ERBB2 amplification and optimizing anti-HER2 therapy in gastric cancer. BMC Cancer. 24(1). 719–719. 1 indexed citations
4.
Ichikawa, Hiroshi, Takashi Ishikawa, Yusuke Muneoka, et al.. (2024). Prognostic Significance of NQO1 Expression in Non-neoplastic Esophageal Squamous Epithelium for Patients With Esophageal Cancer. Anticancer Research. 44(5). 1915–1924.
5.
Moro, Kazuki, Hiroshi Ichikawa, Yu Koyama, et al.. (2023). Oral Administration of Glucosylceramide Suppresses Tumor Growth by Affecting the Ceramide/Sphingosine-1-Phosphate Balance in Breast Cancer Tissue. World Journal of Oncology. 14(5). 430–437.
6.
Ichikawa, Hiroshi, Kazuyasu Takizawa, Masayuki Nagahashi, et al.. (2023). Clinical Significance of Phosphorylated Sphingosine Kinase 1 Expression in Pancreatic Ductal Adenocarcinoma. Anticancer Research. 43(9). 3969–3977. 4 indexed citations
7.
Moro, Kazuki, Masayuki Nagahashi, Junko Tsuchida, et al.. (2022). Advanced Stage Is a Risk for Severe Neutropenia in Breast Cancer Patients Undergoing Neoadjuvant Adriamycin/Cyclophosphamide/Docetaxel Chemotherapy. World Journal of Oncology. 13(6). 379–386. 2 indexed citations
8.
Moro, Kazuki, et al.. (2020). Malignant adenomyoepithelioma of the breast. SHILAP Revista de lepidopterología. 6(1). 118–118. 18 indexed citations
9.
Moro, Kazuki, Masayuki Nagahashi, Emmanuel Gabriel, Kazuaki Takabe, & Toshifumi Wakai. (2019). Clinical application of ceramide in cancer treatment. Breast Cancer. 26(4). 407–415. 43 indexed citations
10.
Moro, Kazuki, Hitoshi Kameyama, Junko Tsuchida, et al.. (2019). Left colic artery aneurysm rupture after stent placement for abdominal aortic aneurysm associated with neurofibromatosis type 1. SHILAP Revista de lepidopterología. 5(1). 12–12. 8 indexed citations
11.
Prasoon, Pankaj, Yuki Hirose, Jun Sakata, et al.. (2019). Early-stage T1b adenocarcinoma arising in the remnant cystic duct after laparoscopic cholecystectomy: a case report and literature review. BMC Surgery. 19(1). 183–183. 3 indexed citations
12.
Koyama, Yu, Kazuki Moro, Masato Nakano, et al.. (2017). Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients. Journal of Clinical Medicine Research. 9(10). 831–837. 3 indexed citations
13.
Moro, Kazuki, Masayuki Nagahashi, Kotaro Hirashima, et al.. (2017). Benign esophageal schwannoma: a brief overview and our experience with this rare tumor. SHILAP Revista de lepidopterología. 3(1). 97–97. 9 indexed citations
14.
Moro, Kazuki, Masayuki Nagahashi, Tetsuya Naito, et al.. (2017). Gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor: a case of a rare malignancy. SHILAP Revista de lepidopterología. 3(1). 67–67. 6 indexed citations
15.
Moro, Kazuki, Yusuke Muneoka, Yu Sato, et al.. (2017). Right-sided Bochdalek hernia in an elderly adult: a case report with a review of surgical management. SHILAP Revista de lepidopterología. 3(1). 109–109. 14 indexed citations
16.
Moro, Kazuki, Masayuki Nagahashi, Rajesh Ramanathan, Kazuaki Takabe, & Toshifumi Wakai. (2016). Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer. World Journal of Clinical Cases. 4(7). 155–155. 73 indexed citations
17.
Nagahashi, Masayuki, Junko Tsuchida, Kazuki Moro, et al.. (2016). High levels of sphingolipids in human breast cancer. Journal of Surgical Research. 204(2). 435–444. 83 indexed citations
18.
Tsuchida, Junko, Masayuki Nagahashi, Masato Nakajima, et al.. (2016). Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis. Journal of Surgical Research. 205(1). 85–94. 57 indexed citations
19.
Koyama, Yu, Masayuki Nagahashi, Kazuki Moro, et al.. (2015). Predictive Factors for Non-Sentinel Lymph Node Metastasis in the Case of Positive Sentinel Lymph Node Metastasis in Two or Fewer Nodes in Breast Cancer. Journal of Clinical Medicine Research. 7(8). 620–626. 14 indexed citations
20.
Nagahashi, Masayuki, Yasunobu Matsuda, Kazuki Moro, et al.. (2015). DNA damage response and sphingolipid signaling in liver diseases. Surgery Today. 46(9). 995–1005. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026